- Home
- ANIP vs RSI Comparison
ANIP vs RSI Comparison
Compare ANIP & RSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANIP
- RSI
- Stock Information
- Founded
- ANIP 2001
- RSI 2012
- Country
- ANIP United States
- RSI United States
- Employees
- ANIP N/A
- RSI N/A
- Industry
- ANIP Biotechnology: Pharmaceutical Preparations
- RSI Services-Misc. Amusement & Recreation
- Sector
- ANIP Health Care
- RSI Consumer Discretionary
- Exchange
- ANIP Nasdaq
- RSI Nasdaq
- Market Cap
- ANIP 2.0B
- RSI 1.6B
- IPO Year
- ANIP N/A
- RSI N/A
- Fundamental
- Price
- ANIP $92.85
- RSI $18.51
- Analyst Decision
- ANIP Strong Buy
- RSI Strong Buy
- Analyst Count
- ANIP 7
- RSI 9
- Target Price
- ANIP $99.14
- RSI $19.25
- AVG Volume (30 Days)
- ANIP 343.4K
- RSI 1.6M
- Earning Date
- ANIP 11-07-2025
- RSI 10-29-2025
- Dividend Yield
- ANIP N/A
- RSI N/A
- EPS Growth
- ANIP N/A
- RSI N/A
- EPS
- ANIP N/A
- RSI 0.26
- Revenue
- ANIP $747,399,000.00
- RSI $1,017,900,000.00
- Revenue This Year
- ANIP $39.99
- RSI $19.69
- Revenue Next Year
- ANIP $9.57
- RSI $16.46
- P/E Ratio
- ANIP N/A
- RSI $71.58
- Revenue Growth
- ANIP 38.68
- RSI 26.99
- 52 Week Low
- ANIP $52.50
- RSI $9.54
- 52 Week High
- ANIP $99.50
- RSI $22.65
- Technical
- Relative Strength Index (RSI)
- ANIP 51.08
- RSI 45.27
- Support Level
- ANIP $90.06
- RSI $17.14
- Resistance Level
- ANIP $96.99
- RSI $19.56
- Average True Range (ATR)
- ANIP 2.63
- RSI 1.08
- MACD
- ANIP 0.06
- RSI 0.02
- Stochastic Oscillator
- ANIP 55.91
- RSI 42.45
About ANIP ANI Pharmaceuticals Inc.
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.
About RSI Rush Street Interactive Inc.
Rush Street Interactive Inc is an online gaming and entertainment company that focuses on online casinos and online sports betting in the U.S. and Latin American markets. It provides customers with an array of gaming offerings such as real-money online casinos, online sports betting, and retail sports betting, as well as social gaming, which involves free-to-play games that use virtual credits that can be earned or purchased. The company generates revenue by offering online casinos, online sports betting, and social gaming directly to the end customer through its websites or apps. The company generates revenue through business-to-consumer (B2C) and business-to-business (B2B) models.